<h4>Background</h4>Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that regulates cellular defense mechanisms and has been proposed as a therapeutic target for Alzheimer's disease (AD). This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.